vimarsana.com

Latest Breaking News On - Boston clinical research institute - Page 1 : vimarsana.com

Clinical Ink: Clinical ink Forms Strategic Alliance with Boston Clinical Research Institute

Alliance Amplifies Clinical ink's Scientific Expertise to Support Improved Patient OutcomesHorsham, PA, Feb. 27, 2023, a global life science technology company, announces an strategic alliance with The

Some needs unmet in secondary CVD prevention despite aspirin use; new agent may have role

Aspirin is the foundational treatment for secondary prevention of cardiac events and the standard therapy I have used for my patients for decades, but it can expose some patients to bleeding risk. For each patient, I balance the benefit-risk ratio and tailor the aspirin (acetylsalicylic acid) therapy to the greatest response and adherence with the lowest risk for bleeding. A recent review article

AngelMed Announces FDA Approval of the Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

AngelMed Announces FDA Approval of the Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.